Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Prolactinoma 1 Pituitary ACTH Hypersecretion 1 Paraproteinemias 1 Pancreatic Ductal Adenocarcinoma 1 Nervous System Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Mesothelioma, Malignant 1 Lung Neoplasms 1 Leiomyosarcoma 1 Immunoglobulin Light-chain Amyloidosis 1 Head and Neck Neoplasms 1 Gigantism 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Congenital Abnormalities 1 Combined Pituitary Hormone Deficiency 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Central Nervous System Neoplasms 1 Central Nervous System Diseases 1 Carcinosarcoma 1

Interventions

Doxorubicin 26 pembrolizumab 24 Radiotherapy 20 Cyclophosphamide 18 Magnetic Resonance Spectroscopy 17 Specimen Handling 14 Nivolumab 14 Gemcitabine 13 Ifosfamide 12 Surgical Procedures, Operative 11 Biopsy 11 Radiation 10 X-Rays 8 Temozolomide 8 Ipilimumab 8 pazopanib 7 fludarabine 7 cabozantinib 7 Irinotecan 7 tazemetostat 6 liposomal doxorubicin 6 Trabectedin 6 Surveys and Questionnaires 6 Phantoms, Imaging 6 Blood Specimen Collection 6 olaparib 5 eribulin 5 atezolizumab 5 anlotinib 5 Vincristine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Tissue Banks × 1 year × Clear all

NCT06482957 2025-09-19

CAUSAL

Vanderbilt-Ingram Cancer Center

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡